A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

NCT07625280 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Narcolepsy
Idiopathic Hypersomnia

Interventions

DRUG: Xywav
OTHER: Placebo

Sponsor

Jazz Pharmaceuticals

Collaborators

[object Object]